JUNO THERAPEUTICS INC's ticker is JUNO and the CUSIP is 48205A109. A total of 176 filers reported holding JUNO THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 0.85 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $0 | -100.0% | 9 | -99.9% | 0.00% | -100.0% |
| Q2 2017 | $484,000 | – | 16,192 | +809500.0% | 0.06% | – |
| Q1 2017 | $0 | -100.0% | 2 | -100.0% | 0.00% | -100.0% |
| Q4 2016 | $140,000 | – | 7,447 | +744600.0% | 0.02% | – |
| Q3 2016 | $0 | -100.0% | 1 | -98.6% | 0.00% | – |
| Q2 2016 | $3,000 | 0.0% | 70 | -15.7% | 0.00% | – |
| Q1 2016 | $3,000 | – | 83 | +2666.7% | 0.00% | – |
| Q4 2015 | $0 | -100.0% | 3 | -70.0% | 0.00% | – |
| Q2 2015 | $1,000 | -95.0% | 10 | -96.9% | 0.00% | -100.0% |
| Q1 2015 | $20,000 | – | 327 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 25,948,799 | $1,132,937,000 | 100.00% |
| Biomark Capital Management Co. LLC | 1,602,562 | $70,465,000 | 85.76% |
| Omega Fund Management, LLC | 1,229,512 | $54,062,000 | 30.09% |
| Clarius Group, LLC | 218,942 | $9,626,000 | 2.93% |
| BB BIOTECH AG | 1,305,000 | $57,381,000 | 1.62% |
| Casdin Capital, LLC | 17,500 | $769,000 | 0.68% |
| Rock Springs Capital Management LP | 197,001 | $8,662,000 | 0.66% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 38,850 | $1,708,000 | 0.55% |
| ArrowMark Colorado Holdings LLC | 383,749 | $16,873,000 | 0.46% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 68,848 | $3,027,000 | 0.38% |